TCL Archive John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions. October 7, 2005
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014